Castle Biosciences CSTL Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on trailing twelve months.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's free cash flow yield?
- Castle Biosciences (CSTL) reported free cash flow yield of 0.6% in Q1 2026.
- How has Castle Biosciences's free cash flow yield changed year-over-year?
- Castle Biosciences's free cash flow yield decreased by 91.5% year-over-year, from 7.3% to 0.6%.
- What is the long-term trend for Castle Biosciences's free cash flow yield?
- Over 3 years (2021 to 2025), Castle Biosciences's free cash flow yield has grown at a 6.4% compound annual growth rate (CAGR), from -2.1% to 2.5%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.